Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Reunion Neuroscience Inc T.REUN

Reunion Neuroscience Inc. is engaged in the psychedelic drug development company that provides therapeutic solutions for mental health conditions by developing serotonin receptor agonist compounds. The Company is developing the advancement of synthetic molecules targeting serotonin 5HT2A receptors. The Company’s products include RE104 and RE200. The Company’s lead asset, RE-104, which is a... see more

Recent & Breaking News (TSX:REUN)

Field Trip Health Ltd. to Present at the Cowen Psychedelics & Novel Mechanisms in Neuropsychiatry Summit

GlobeNewswire July 8, 2021

Field Trip Health (TSX:FTRP) Applies to List on the NASDAQ Stock Market

John Ballem  June 8, 2021

Field Trip Health Ltd. to Commence Trading on the Toronto Stock Exchange on June 7, 2021

GlobeNewswire June 3, 2021

CSE Bulletin: Delist - Field Trip Health Ltd. (FTRP, FTRP.WT)

Newsfile June 2, 2021

This is Why Psilocybin May be Able to Help Millions with Mental Health Issue

Press Releases May 28, 2021

Field Trip Health (CSE:FTRP) receives conditional approval to list on the TSX

John Ballem  May 27, 2021

Field Trip Health Ltd. Receives Conditional Approval to Up-List to the Toronto Stock Exchange

GlobeNewswire May 27, 2021

Former Senate Majority Leader Tom Daschle Appointed Special Adviser to Field Trip Health Ltd.

GlobeNewswire May 20, 2021

Psychedelic Stocks Might Take Off In 2021

Press Releases May 19, 2021

Canadians Are Not OK, 83% of Canadians Report One Or More Symptoms of Depression With Many Turning To Substances To Cope With Negative Emotions During COVID-19 Pandemic, According to Field Trip Health's First Annual "State of Mind" Survey

Canada NewsWire May 18, 2021

More than 80% of Americans report one or more symptoms of depression, and many have turned to substances to cope with negative emotions during COVID-19 Pandemic, according to Field Trip Health's First Annual "State of Mind" Survey

GlobeNewswire May 18, 2021

Field Trip Health Ltd. (CSE:FTRP) reports DTC eligibility

Brieanna McCutcheon  May 6, 2021

Field Trip Health Ltd. Announces DTC Eligibility

GlobeNewswire May 6, 2021

Field Trip Health Ltd. Announces Opening of Psychedelic-Enhanced Therapy Center in Houston; Locations of Next 5 Field Trip Health Centers

Stockhouse.com May 4, 2021

Music May Play a Critical Role in Psychedelic Therapy Sessions

Livemoney April 6, 2021

Field Trip Health Ltd. Announces Closing of $95 Million Bought Deal Financing

GlobeNewswire March 17, 2021

Innovators Identify Crucial Advancements to Uncover Medical Breakthroughs From Psychedelics

Livemoney March 2, 2021

Psilocybin Could Help Curb Cravings and Shut Off Appetite

Livemoney March 2, 2021

Field Trip Health (CSE:FTRP) announces upsize to bought deal public offering

John Ballem  February 26, 2021

IIROC Trade Resumption - FTRP

Canada NewsWire February 26, 2021